These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34080358)

  • 21. Remodeling the Microenvironment before Occurrence and Metastasis of Cancer.
    Zhang X; Xiang J
    Int J Biol Sci; 2019; 15(1):105-113. PubMed ID: 30662351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oncofetal reprogramming in tumour development and progression.
    Sharma A; Blériot C; Currenti J; Ginhoux F
    Nat Rev Cancer; 2022 Oct; 22(10):593-602. PubMed ID: 35999292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumour microenvironment and metabolic plasticity in cancer and cancer stem cells: Perspectives on metabolic and immune regulatory signatures in chemoresistant ovarian cancer stem cells.
    Ahmed N; Escalona R; Leung D; Chan E; Kannourakis G
    Semin Cancer Biol; 2018 Dec; 53():265-281. PubMed ID: 30317036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumour progression and metastasis.
    Arvelo F; Sojo F; Cotte C
    Ecancermedicalscience; 2016; 10():617. PubMed ID: 26913068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An apoptosis-driven 'onco-regenerative niche': roles of tumour-associated macrophages and extracellular vesicles.
    Gregory CD; Paterson M
    Philos Trans R Soc Lond B Biol Sci; 2018 Jan; 373(1737):. PubMed ID: 29158317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gap junction as an intercellular glue: Emerging roles in cancer EMT and metastasis.
    Mao XY; Li QQ; Gao YF; Zhou HH; Liu ZQ; Jin WL
    Cancer Lett; 2016 Oct; 381(1):133-7. PubMed ID: 27490999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional and genetic deconstruction of the cellular origin in liver cancer.
    Marquardt JU; Andersen JB; Thorgeirsson SS
    Nat Rev Cancer; 2015 Nov; 15(11):653-67. PubMed ID: 26493646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer Cell Colonisation in the Bone Microenvironment.
    Kan C; Vargas G; Pape FL; Clézardin P
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27782035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lineage plasticity in prostate cancer: Looking beyond intrinsic alterations.
    Ferguson AM; Rubin MA
    Cancer Lett; 2022 Nov; 548():215901. PubMed ID: 36075486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of inflammation-associated microenvironment in tumorigenesis and metastasis.
    Gao F; Liang B; Reddy ST; Farias-Eisner R; Su X
    Curr Cancer Drug Targets; 2014; 14(1):30-45. PubMed ID: 24200082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mesenchymal stromal cells (MSCs) and colorectal cancer: a troublesome twosome for the anti-tumour immune response?
    O'Malley G; Heijltjes M; Houston AM; Rani S; Ritter T; Egan LJ; Ryan AE
    Oncotarget; 2016 Sep; 7(37):60752-60774. PubMed ID: 27542276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Zebrafish Microenvironment Elevates EMT and CSC-Like Phenotype of Engrafted Prostate Cancer Cells.
    Chen L; Boleslaw Olszewski M; Kruithof-de Julio M; Snaar-Jagalska BE
    Cells; 2020 Mar; 9(4):. PubMed ID: 32225005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pre-metastatic niches: organ-specific homes for metastases.
    Peinado H; Zhang H; Matei IR; Costa-Silva B; Hoshino A; Rodrigues G; Psaila B; Kaplan RN; Bromberg JF; Kang Y; Bissell MJ; Cox TR; Giaccia AJ; Erler JT; Hiratsuka S; Ghajar CM; Lyden D
    Nat Rev Cancer; 2017 May; 17(5):302-317. PubMed ID: 28303905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Secreted molecules inducing epithelial-to-mesenchymal transition in cancer development.
    Dalla Pozza E; Forciniti S; Palmieri M; Dando I
    Semin Cell Dev Biol; 2018 Jun; 78():62-72. PubMed ID: 28673679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epithelial, mesenchymal and hybrid epithelial/mesenchymal phenotypes and their clinical relevance in cancer metastasis.
    Garg M
    Expert Rev Mol Med; 2017 Mar; 19():e3. PubMed ID: 28322181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exosomes: Dynamic Mediators of Extracellular Communication in the Tumor Microenvironment.
    Wolf-Dennen K; Kleinerman ES
    Adv Exp Med Biol; 2020; 1258():189-197. PubMed ID: 32767243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epithelial-to-mesenchymal transition as the driver of changing carcinoma and glioblastoma microenvironment.
    Majc B; Sever T; Zarić M; Breznik B; Turk B; Lah TT
    Biochim Biophys Acta Mol Cell Res; 2020 Oct; 1867(10):118782. PubMed ID: 32554164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stem Cells in Tumour Microenvironment Aid in Prolonged Survival Rate of Cancer Cells and Developed Drug Resistance: Major Challenge in Osteosarcoma Treatment.
    Birru B; Durthi CP; Kacham S; Pola M; Rajulapati SB; Parcha SR; Kamal MA
    Curr Drug Metab; 2020; 21(1):44-52. PubMed ID: 32056519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression.
    Cirri P; Chiarugi P
    Cancer Metastasis Rev; 2012 Jun; 31(1-2):195-208. PubMed ID: 22101652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mesenchymal stem cells: key players in cancer progression.
    Ridge SM; Sullivan FJ; Glynn SA
    Mol Cancer; 2017 Feb; 16(1):31. PubMed ID: 28148268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.